Track record · closed signal

Novavax Inc (NVAX) — closed signal from April 26, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on July 25, 2026.

Predicted vs. what happened

NVAX price · publication thesis → realized outcomesplit-adjusted
$8.22 Published $10.19 Target $7.46 Window close $11.61 Peak
$7.70 – $8.50Entry zone — fair-value band
$8.22Published — price the day we called it
$10.19Target — the price the thesis aimed for
$11.61Peak — highest point inside the window, not a realized return
$7.46Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 11 days.

Peak price
$11.61
peak on May 27, 2026 — not a realized return
Peak gain
+41.2%
peak, from the publication price
Window close
$7.46
end-of-window price, context only
Days to target
11
Window
April 26, 2026 – July 25, 2026

The thesis — published April 26, 2026

Predicted growth
+24%
over the measurement window
Target price
$10.19
the price the thesis aimed for
Entry zone
$7.70 – $8.50
the fair-value band we waited for
Price at publication
$8.22
published April 26, 2026
Confidence
68%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novavax is a risky healthcare rebound pick. Recent analyst attention and tolerability data give the stock a new positive story. The company has more cash than many small biotech peers, which helps near-term prospects. However, earnings swings and the chance of clinical or regulatory setbacks make the short-term outlook speculative despite meaningful upside potential.

Primary drivers

  • Analyst coverage renewed a turnaround story
  • Tolerability data strengthens the product story
  • Stronger cash position than many small biotechs
  • Oversold stock and heavy shorting can spark rebounds

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All NVAX signals